ClinicalTrials.govpublic full text
Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma
scleroderma, interstitial lung disease, ssc, systemic sclerosis, cutaneous systemic sclerosis, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 886821
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.